Erik de Vries strengthens Enzymes business development
Dr. Erik de Vries becomes Senior Director Business Development Enzymes and will support BRAIN Biotech AG as Senior Business Development Director Enzymes from June 1, 2024.
The PhD chemist has a wealth of experience in the field of enzymes, which he has gained from his activities at renowned enzyme companies such as Codexis and Amyris as well as from his activities in supporting numerous biotech and deep-tech start-up initiatives.
Dr. Martin Langer, Managing Director & Executive Vice President BioScience of BRAIN Biotech AG, welcomes Erik de Vries to the BRAIN Biotech Group: "Erik is very well connected in the enzyme world and knows the advantages of our proprietary technology packages, such as advanced microbial production strains, genome editing tools, as well as the easy access to novel enzymes through our metagenome libraries. With his deep insight into markets such as pharma, food, feed and beverage and knowledge of the needs of the players in these markets, he is the right person and a perfect fit to support BRAIN Biotech's business development team in Zwingenberg. I look forward to working with Erik to build on the synergies between Enzymicals and BRAIN and further advance our business with customized solutions."